Top

Published in:

01-04-2021 | Nimodipine | Review

Non-steroidal anti-inflammatory drugs in the pathophysiology of vasospasms and delayed cerebral ischemia following subarachnoid hemorrhage: a critical review

Authors: Peter Solar, Zdenek Mackerle, Marek Joukal, Radim Jancalek

Published in: Neurosurgical Review | Issue 2/2021

Abstract

Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening condition associated with the development of early brain injury (EBI) and delayed cerebral ischemia (DCI). Pharmacological treatment of vasospasm following aSAH currently mainly comprises nimodipine administration. In the past few years, many drugs that can potentially benefit cases of subarachnoid hemorrhage have become available. The objective of this review is to critically assess the effects of non-steroidal anti-inflammatory drugs (NSAIDs) following aSAH. A systematic literature review was conducted following PRISMA guidelines. The search was aimed at studies addressing aSAH and NSAIDs during the 2010 to 2019 period, and it yielded 13 articles. Following the application of search criteria, they were divided into two groups, one containing 6 clinical articles and the other containing 7 experimental articles on animal models of aSAH. Inflammatory cerebral changes after aneurysm rupture contribute to the development of EBI, DCI and cerebral vasospasm. It appears that NSAIDs (especially coxibs) are even more effective in reducing vasospasm than nimodipine. Other beneficial effects of NSAIDs include reduction in mortality, improved functional outcome and increased hypoaggregability. However, despite these positive effects, there is only one randomized, double-blind, placebo-controlled trial showing a tendency towards a better outcome with lower incidence of vasospasm or mortality in patients following aSAH.

Available only for authorised users

Ansar S, Larsen C, Maddahi A, Edvinsson L (2010) Subarachnoid hemorrhage induces enhanced expression of thromboxane A2 receptors in rat cerebral arteries. Brain Res 1316:163–172. https://doi.org/10.1016/j.brainres.2009.12.031CrossRefPubMed

Brueggemann LI, Mani BK, Mackie AR, Cribbs LL, Byron KL (2010) Novel actions of nonsteroidal anti-inflammatory drugs on vascular ion channels: accounting for cardiovascular side effects and identifying new therapeutic applications. Mol Cell Pharmacol 2:15–19PubMedPubMedCentral

Brune K, Patrignani P (2015) New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res 8:105–118. https://doi.org/10.2147/JPR.S75160CrossRefPubMedPubMedCentral

Çelik Ö, Bilginer B, Korkmaz A, Gürgör PN, Bavbek M, Özgen T, Ziyal İ (2011) Effects of intramuscular parecoxib administration on vasospasm in an experimental subarachnoid hemorrhage model. Int J Neurosci 121:316–322. https://doi.org/10.3109/00207454.2011.556284CrossRefPubMed

Chang C-Z, Wu S-C, Lin C-L, Kwan A-L (2015) Parecoxib, a selective cyclooxygenase inhibitor, attenuates C-Jun N-terminal kinase activation in experimental subarachnoid hemorrhage induced early brain injury. J Neurol Neurophysiol 6. https://doi.org/10.4172/2155-9562.1000294

Choi HA, Ko S-B, Chen H, Gilmore E, Carpenter AM, Lee D, Claassen J, Mayer SA, Schmidt JM, Lee K, Connelly ES, Paik M, Badjatia N (2012) Acute effects of nimodipine on cerebral vasculature and brain metabolism in high grade subarachnoid hemorrhage patients. Neurocrit Care 16:363–367. https://doi.org/10.1007/s12028-012-9670-8CrossRefPubMed

Etminan N, Chang H-S, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, Algra A (2019) Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol 76:588–597. https://doi.org/10.1001/jamaneurol.2019.0006CrossRefPubMedPubMedCentral

Fisher CL, Demel SL (2019) Nonsteroidal anti-inflammatory drugs: a potential pharmacological treatment for intracranial aneurysm. Cerebrovasc Dis Extra 9:31–45. https://doi.org/10.1159/000499077CrossRefPubMedPubMedCentral

Frontera JA, Provencio JJ, Sehba FA, McIntyre TM, Nowacki AS, Gordon E, Weimer JM, Aledort L (2017) The role of platelet activation and inflammation in early brain injury following subarachnoid hemorrhage. Neurocrit Care 26:48–57. https://doi.org/10.1007/s12028-016-0292-4CrossRefPubMedPubMedCentral

10.

Ghodsi SM, Mohebbi N, Naderi S, Anbarloie M, Aoude A, Habibi Pasdar SS (2015) Comparative efficacy of meloxicam and placebo in vasospasm of patients with subarachnoid hemorrhage. Iran J Pharm Res IJPR 14:125–130PubMed

11.

Hinz B, Cheremina O, Brune K (2007) Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J. https://doi.org/10.1096/fj.07-8506com

12.

Jack H, Zhang JH (2013) Does prevention of vasospasm in subarachnoid hemorrhage improve clinical outcome? No. Stroke 44:S34–S36. https://doi.org/10.1161/STROKEAHA.111.000686CrossRef

13.

Huang H, Al-Shabrawey M, Wang M-H (2016) Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke. Prostaglandins Other Lipid Mediat 122:45–53. https://doi.org/10.1016/j.prostaglandins.2015.12.007CrossRefPubMed

14.

Imai T, Iwata S, Hirayama T, Nagasawa H, Nakamura S, Shimazawa M, Hara H (2019) Intracellular Fe 2+ accumulation in endothelial cells and pericytes induces blood-brain barrier dysfunction in secondary brain injury after brain hemorrhage. Sci Rep 9:1–16. https://doi.org/10.1038/s41598-019-42370-zCrossRef

15.

Schiefecker AJ, Rass V, Gaasch M, Kofler M, Thomé C, Humpel C, Ianosi B, Hackl WO, Beer R, Pfausler B, Schmutzhard E, Helbok R (2019) Brain extracellular interleukin-6 levels decrease following antipyretic therapy with diclofenac in patients with spontaneous subarachnoid hemorrhage. Ther Hypothermia Temp Manag 9(1):48–55. https://doi.org/10.1089/ther.2018.0001CrossRefPubMed

16.

Jasiecka A, Maślanka T, Jaroszewski JJ (2014) Pharmacological characteristics of metamizole. Pol J Vet Sci 17:207–214CrossRefPubMed

17.

Jedrzejowska-Szypulka H, Larysz-Brysz M, Kukla M, Snietura M, Lewin-Kowalik J (2009) Neutralization of interleukin-1β reduces vasospasm and alters cerebral blood vessel density following experimental subarachnoid hemorrhage in rats. https://www.ingentaconnect.com/content/ben/cnr/2009/00000006/00000002/art00003.

18.

Ji X, Nishihashi T, Trandafir CC, Wang A, Shimizu Y, Kurahashi K (2007) Pharmacological nature of nicotine-induced contraction in the rat basilar artery: involvement of arachidonic acid metabolites. Eur J Pharmacol 577:109–114. https://doi.org/10.1016/j.ejphar.2007.08.011CrossRefPubMed

19.

Ji X, Wang A, Trandafir CC, Kurahashi K (2013) Influence of experimental subarachnoid hemorrhage on nicotine-induced contraction of the rat basilar artery in relation to arachidonic acid metabolites signaling pathway. J Stroke Cerebrovasc Dis 22:951–958. https://doi.org/10.1016/j.jstrokecerebrovasdis.2011.12.001CrossRefPubMed

20.

Kim GH, Kellner CP, Hahn DK, Desantis BM, Musabbir M, Starke RM, Rynkowski M, Komotar RJ, Otten ML, Sciacca R, Schmidt JM, Mayer SA, Connolly ES (2008) Monocyte chemoattractant protein–1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 109:38–43. https://doi.org/10.3171/JNS/2008/109/7/0038CrossRefPubMed

21.

Laher I, Zhang JH (2001) Protein kinase C and cerebral vasospasm. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 21:887–906. https://doi.org/10.1097/00004647-200108000-00001CrossRef

22.

Lauritzen M, Dreier JP, Fabricius M, Hartings JA, Graf R, Strong AJ (2011) Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab 31:17–35. https://doi.org/10.1038/jcbfm.2010.191CrossRefPubMed

23.

Leese PT, Hubbard RC, Karim A, Isakson PC, Yu SS, Geis GS (2000) Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol 40:124–132. https://doi.org/10.1177/00912700022008766CrossRefPubMed

24.

Li Y, Luo D, Chen X, Li J, Yan L, Li T, Zhao Y, Liu H, Ji X, Ma X (2017) Involvement of arachidonic acid metabolites pathway and nicotinic acetylcholine receptors (nAChRs) on nicotine-induced contractions (or relaxations) in the basilar artery. Int J Pharmacol 13:1–10. https://doi.org/10.3923/ijp.2017.1.10CrossRef

25.

Young AM, Karri SK, Ogilvy CS (2012) Non-steroidal anti-inflammatory drugs used as a treatment modality in subarachnoid hemorrhage. https://www.ingentaconnect.com/content/ben/cds/2012/00000007/00000003/art00003.

26.

Mani BK, Brueggemann LI, Cribbs LL, Byron KL (2011) Activation of vascular KCNQ (Kv7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery. Br J Pharmacol 164:237–249. https://doi.org/10.1111/j.1476-5381.2011.01273.xCrossRefPubMedPubMedCentral

27.

Mani BK, O’Dowd J, Kumar L, Brueggemann LI, Ross M, Byron KL (2013) Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm. J Cardiovasc Pharmacol 61:51–62. https://doi.org/10.1097/FJC.0b013e3182771708CrossRefPubMedPubMedCentral

28.

Mee E, Dorrance D, Lowe D, Neil-Dwyer G (1988) Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery 22:484–491. https://doi.org/10.1227/00006123-198803000-00006CrossRefPubMed

29.

Miller BA, Turan N, Chau M, Pradilla G (2014) Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage. Biomed Res Int 2014:1–16. https://doi.org/10.1155/2014/384342CrossRef

30.

Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6:e1000097. https://doi.org/10.1371/journal.pmed.1000097CrossRefPubMedPubMedCentral

31.

Munakata A, Naraoka M, Katagai T, Shimamura N, Ohkuma H (2016) Role of cyclooxygenase-2 in relation to nitric oxide and endothelin-1 on pathogenesis of cerebral vasospasm after subarachnoid hemorrhage in rabbit. Transl Stroke Res 7:220–227. https://doi.org/10.1007/s12975-016-0466-6CrossRefPubMed

32.

Muroi C, Hugelshofer M, Seule M, Keller E (2014) The impact of nonsteroidal anti-inflammatory drugs on inflammatory response after aneurysmal subarachnoid hemorrhage. Neurocrit Care 20:240–246. https://doi.org/10.1007/s12028-013-9930-2CrossRefPubMed

33.

Nassiri F, Ibrahim GM, Badhiwala JH, Witiw CD, Mansouri A, Alotaibi NM, Macdonald RL (2016) A propensity score-matched study of the use of non-steroidal anti-inflammatory agents following aneurysmal subarachnoid hemorrhage. Neurocrit Care 25:351–358. https://doi.org/10.1007/s12028-016-0266-6CrossRefPubMed

34.

de Oliveira Manoel AL, Macdonald RL (2018) Neuroinflammation as a target for intervention in subarachnoid hemorrhage. Front Neurol 9. https://doi.org/10.3389/fneur.2018.00292

35.

Olsen MH, Orre M, Leisner ACW, Rasmussen R, Bache S, Welling K-L, Eskesen V, Møller K Delayed cerebral ischaemia in patients with aneurysmal subarachnoid haemorrhage: functional outcome and long-term mortality. Acta Anaesthesiol Scand 63(9):1191–1199. https://doi.org/10.1111/aas.13412

36.

Parkhutik V, Lago A, Tembl JI, Rubio C, Fuset MP, Vallés J, Santos MT, Moscardo A (2012) Influence of COX-inhibiting analgesics on the platelet function of patients with subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 21:755–759. https://doi.org/10.1016/j.jstrokecerebrovasdis.2011.04.002CrossRefPubMed

37.

Peeyush Kumar T, McBride DW, Dash PK, Matsumura K, Rubi A, Blackburn SL (2019) Endothelial cell dysfunction and injury in subarachnoid hemorrhage. Mol Neurobiol 56:1992–2006. https://doi.org/10.1007/s12035-018-1213-7CrossRefPubMed

38.

Petruk KC, West M, Mohr G, Weir BKA, Benoit BG, Gentili F, Disney LB, Khan MI, Grace M, Holness RO, Karwon MS, Ford RM, Cameron GS, Tucker WS, Purves GB, Miller JDR, Hunter KM, Richard MT, Durity FA, Chan R, Clein LJ, Maroun FB, Godon A (1988) Nimodipine treatment in poor-grade aneurysm patients: results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68:505–517. https://doi.org/10.3171/jns.1988.68.4.0505CrossRefPubMed

39.

Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298:636–642CrossRefPubMedPubMedCentral

40.

Pluta RM (2008) Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Acta Neurochir Suppl 104:139–147CrossRefPubMedPubMedCentral

41.

Pluta RM, Afshar JK, Boock RJ, Oldfield EH (1998) Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage. J Neurosurg 88:557–561. https://doi.org/10.3171/jns.1998.88.3.0557CrossRefPubMed

42.

Porchet F, Chioléro R, de Tribolet N (1995) Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage. Acta Neurochir 137:62–69. https://doi.org/10.1007/BF02188783CrossRefPubMed

43.

Prunell GF, Mathiesen T, Diemer NH, Svendgaard N-A (2003) Experimental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models. Neurosurgery 52:165–175; discussion 175-176. https://doi.org/10.1097/00006123-200301000-00022CrossRefPubMed

44.

Rogosch T, Sinning C, Podlewski A, Watzer B, Schlosburg J, Lichtman AH, Cascio MG, Bisogno T, Di Marzo V, Nüsing R, Imming P (2012) Novel bioactive metabolites of dipyrone (metamizol). Bioorg Med Chem 20:101–107. https://doi.org/10.1016/j.bmc.2011.11.028CrossRefPubMed

45.

Sabri M, Lass E, Macdonald RL (2013) Early brain injury: a common mechanism in subarachnoid hemorrhage and global cerebral ischemia. Stroke Res. Treat, In https://www.hindawi.com/journals/srt/2013/394036/.

46.

Schiefecker AJ, Pfausler B, Beer R, Sohm F, Sabo J, Knauseder V, Fischer M, Dietmann A, Hackl WO, Thomé C, Schmutzhard E, Helbok R (2013) Parenteral diclofenac infusion significantly decreases brain-tissue oxygen tension in patients with poor-grade aneurysmal subarachnoid hemorrhage. Crit Care 17:R88. https://doi.org/10.1186/cc12714CrossRefPubMedPubMedCentral

47.

Schiefecker AJ, Rass V, Gaasch M, Kofler M, Thomé C, Humpel C, Ianosi B, Hackl WO, Beer R, Pfausler B, Schmutzhard E, Helbok R (2018) Brain extracellular interleukin-6 levels decrease following antipyretic therapy with diclofenac in patients with spontaneous subarachnoid hemorrhage. Ther Hypothermia Temp Manag 9:48–55. https://doi.org/10.1089/ther.2018.0001CrossRefPubMed

48.

Sehba FA, Bederson JB (2006) Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol Res 28:381–398CrossRefPubMed

49.

Silav G, Ergün H, Dolgun H, Sancak T, Sargon MF, Egemen N (2017) Dipyrone attenuates cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. J Neurosurg Sci 61:380–387. https://doi.org/10.23736/S0390-5616.16.03068-XCrossRefPubMed

50.

Stanley C, O’Sullivan SE (2014) Vascular targets for cannabinoids: animal and human studies. Br J Pharmacol 171:1361–1378. https://doi.org/10.1111/bph.12560CrossRefPubMedPubMedCentral

51.

Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G (2013) European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 35:93–112. https://doi.org/10.1159/000346087CrossRefPubMed

52.

Thampatty BP, Sherwood PR, Gallek MJ, Crago EA, Ren D, Hricik AJ, Kuo C-WJ, Klamerus MM, Alexander SA, Bender CM, Hoffman LA, Horowitz MB, Kassam AB, Poloyac SM (2011) Role of endothelin-1 in human aneurysmal subarachnoid hemorrhage: associations with vasospasm and delayed cerebral ischemia. Neurocrit Care 15:19–27. https://doi.org/10.1007/s12028-011-9508-9CrossRefPubMedPubMedCentral

53.

Tran Dinh Y, Jomaa A, Callebert J, Reynier-Rebuffel AM, Tedgui A, Savarit A, Sercombe R (2001) Overexpression of cyclooxygenase-2 in rabbit basilar artery endothelial cells after subarachnoid hemorrhage. Neurosurgery 48:626–633; discussion 633. https://doi.org/10.1097/00006123-200103000-00037CrossRefPubMed

54.

Vellimana AK, Milner E, Azad TD, Harries MD, Zhou M-L, Gidday JM, Han BH, Zipfel GJ (2011) Endothelial nitric oxide synthase mediates endogenous protection against subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 42:776–782. https://doi.org/10.1161/STROKEAHA.110.607200CrossRefPubMed

55.

Vergouwen Mervyn DI, Don I, Loch MR (2011) Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 42:924–929. https://doi.org/10.1161/STROKEAHA.110.597914CrossRefPubMed

56.

Weir BK, Kongable GL, Kassell NF, Schultz JR, Truskowski LL, Sigrest A (1998) Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the Cooperative Aneurysm Study. J Neurosurg 89:405–411. https://doi.org/10.3171/jns.1998.89.3.0405CrossRefPubMed

Title: Non-steroidal anti-inflammatory drugs in the pathophysiology of vasospasms and delayed cerebral ischemia following subarachnoid hemorrhage: a critical review
Authors: Peter Solar
Zdenek Mackerle
Marek Joukal
Radim Jancalek
Publication date: 01-04-2021
Publisher: Springer Berlin Heidelberg
Keywords: Nimodipine
Subarachnoid Hemorrhage
Diclofenac
Subarachnoid Hemorrhage
Celecoxib
Parecoxib
Published in: Neurosurgical Review / Issue 2/2021
Print ISSN: 0344-5607
Electronic ISSN: 1437-2320
DOI: https://doi.org/10.1007/s10143-020-01276-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Non-steroidal anti-inflammatory drugs in the pathophysiology of vasospasms and delayed cerebral ischemia following subarachnoid hemorrhage: a critical review

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2021

Stereotactic radiosurgery for management of vestibular schwannoma: a short review

Safety and efficacy of surgical treatment for brainstem hemangioblastoma: a meta-analysis

Supplementing decompression with instrumented fusion for symptomatic lumbar spinal stenosis—a critical appraisal of available randomized controlled trials

The right hemisphere is important for driving-related cognitive function after stroke

Risk factors for wound-related complications after microvascular decompression

Natural history of incidentally diagnosed brainstem cavernous malformations in a prospective observational cohort